ProfileGDS4718 / 210445_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 45% 48% 49% 49% 41% 83% 82% 49% 49% 48% 45% 44% 81% 75% 74% 46% 47% 57% 88% 77% 46% 44% 44% 40% 41% 84% 51% 73% 42% 85% 75% 95% 56% 43% 84% 84% 81% 45% 45% 46% 49% 81% 79% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2503345
GSM549102patient 115, normal, homogenized [OPG study]5.4296548
GSM549104patient 119, normal, homogenized [OPG study]5.4316849
GSM549108patient 138, normal, homogenized [OPG study]5.5203749
GSM549119patient 077, normal, homogenized [OPG study]5.0532141
GSM549133patient 032, cancer, homogenized [OPG study]8.3330383
GSM549139patient 042, cancer, homogenized [OPG study]8.0726582
GSM549099patient 107, normal, homogenized [OPG study]5.4886449
GSM549109patient 139, normal, homogenized [OPG study]5.4710349
GSM549110patient 046, normal, homogenized [OPG study]5.4293648
GSM549114patient 063, normal, homogenized [OPG study]5.1759145
GSM549122patient 082, normal, homogenized [OPG study]5.2197244
GSM549134patient 033, cancer, homogenized [OPG study]8.0348781
GSM549136patient 036, cancer, homogenized [OPG study]7.4394475
GSM549140patient 044, cancer, homogenized [OPG study]7.2784874
GSM549111patient 047, normal, homogenized [OPG study]5.2837746
GSM549113patient 057, normal, homogenized [OPG study]5.2656647
GSM549132patient 031, cancer, homogenized [OPG study]5.9204857
GSM549137patient 038, cancer, homogenized [OPG study]8.881988
GSM549142patient 047, cancer, homogenized [OPG study]7.3922777
GSM549100patient 110, normal, homogenized [OPG study]5.3267146
GSM549107patient 135, normal, homogenized [OPG study]5.1690244
GSM549115patient 068, normal, homogenized [OPG study]5.1372744
GSM549116patient 072, normal, homogenized [OPG study]4.9808340
GSM549120patient 078, normal, homogenized [OPG study]5.0471341
GSM549131patient 030, cancer, homogenized [OPG study]8.4551584
GSM549118patient 074, normal, homogenized [OPG study]5.5614551
GSM549129patient 027, cancer, homogenized [OPG study]7.1701973
GSM549123patient 088, normal, homogenized [OPG study]5.052842
GSM549124patient 006, cancer, homogenized [OPG study]8.3499685
GSM549126patient 015, cancer, homogenized [OPG study]7.3672575
GSM549128patient 025, cancer, homogenized [OPG study]10.108495
GSM549103patient 117, normal, homogenized [OPG study]5.8782656
GSM549117patient 073, normal, homogenized [OPG study]5.085143
GSM549138patient 041, cancer, homogenized [OPG study]8.35784
GSM549141patient 045, cancer, homogenized [OPG study]8.3936184
GSM549130patient 028, cancer, homogenized [OPG study]7.9503681
GSM549101patient 111, normal, homogenized [OPG study]5.2841445
GSM549105patient 128, normal, homogenized [OPG study]5.275545
GSM549106patient 134, normal, homogenized [OPG study]5.2664746
GSM549112patient 048, normal, homogenized [OPG study]5.4297149
GSM549125patient 011, cancer, homogenized [OPG study]7.9495181
GSM549127patient 024, cancer, homogenized [OPG study]7.8314279
GSM549135patient 035, cancer, homogenized [OPG study]9.2620290